Insider Transactions Reported by 21 Insiders of Insight Molecular Diagnostics Inc.

Symbol
IMDX on Nasdaq
Location
Nashville, TN

Insiders trading volume in the past year

Insight Molecular Diagnostics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BROADWOOD PARTNERS, L.P. 10%+ Owner $46,781,410 +$10,589,675 +29% 06 Feb 2025
Patrick W. Smith 10%+ Owner $6,679,894 +$2,219,357 +50% 07 Feb 2025
PURA VIDA INVESTMENTS, LLC 10%+ Owner $3,044,309 14 Apr 2023
Andrea James Chief Financial Officer $1,368,300 +$200,000 +17% 31 Oct 2025
Josh Riggs CEO and President, Director $386,792 28 Sep 2025
Andrew Arno Director $381,104 01 Jul 2025
John Peter Gutfreund Former Director $153,654 30 Jun 2023
RONALD ASBURY ANDREWS Former CEO, Director $125,332 01 Dec 2022
ALFRED D. KINGSLEY Director $109,143 23 Jun 2023
Andrew J. Last Director $104,303 01 Jul 2025
LOU SILVERMAN Director $96,528 01 Jul 2025
Gisela Paulsen Former President and COO $78,761 16 Dec 2022
Li Yu VP Cntrllr/Prncpl Acctng Offcr $76,536 18 May 2022
Douglas Ross Former CSO $50,311 21 Dec 2022
James Liu VP ACCT, Cntlr, Treasurer, PAO $38,677 28 Sep 2025
Cavan M. Redmond Director $25,973 24 Jun 2022
Mitchell S. Levine Chief Financial Officer $18,713 15 Mar 2022
Jennifer Levin Carter Director $6,554 15 Aug 2022
Melinda Griffith Director $6,447 15 Aug 2022
Anish John Chief Financial Officer 24 Feb 2023
Padmavathi Sundar Chief Commercial Officer 15 Mar 2022

Recent Insider Transactions by Companies or Individuals for Insight Molecular Diagnostics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.